Showing 1031-1040 of 3550 results for "".
DermWireTV: Opzelura for Vitiligo; Biosimilars Boom; Updates from BTL and Cynosure; DIS Launch
https://practicaldermatology.com/topics/psoriasis/dermwiretv-opzelura-for-vitiligo-biosimilars-boom-updates-from-btl-and-cynosure-dis-launch/20109/FDA has approved Opzelura (ruxolitinib cream 1.5%, Incyte) for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Analysts predict that use of biosimilars in the US is about to increase significantly as Humira (adalimumab, AbbVie) faces patent eInbound Marketing: Why You Need a Strategy
https://practicaldermatology.com/topics/practice-management/inbound-marketing/18782/Focus on cultivating interactive marketing messages to show your audience what your practice is all about and what value it offers your target audience. "In your face" marketing is a thing of the past. Learn three strategies for successful inbound marketing for a medical practice in this Ekwa.com EISDPA: Society Leadership Discusses Issues Facing PAs
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-society-leadership-discusses-issues-facing-pas/27067/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about the latest issues facing physicians assistants with Illinois Society of Dermatology Physician Assistants (ISDPA) leaders Jang-Mi Johnson, PA-C; Sarah Anderson, PA-C; Jordan Stemer, PA-C; and Andrew Mastro, PA-C, at the ISDYour Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/21154/New in My Practice: Serum/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-serumnew-products/23888/BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianUnpacking the Latest CMS Proposal
https://practicaldermatology.com/topics/practice-management/unpacking-the-latest-cms-proposal/20349/What might these changes mean for dermatologists?The Colemans: Dermatology as a Father-Son(s) Tradition
https://practicaldermatology.com/topics/feature/colemans-dermatology-father-sons-tradition/26956/The Colemans: Dermatology as a Father-Son(s) TraditionUnderstanding the SGR: An Explainer
https://practicaldermatology.com/topics/practice-management/understanding-the-sgr-an-explainer/21194/How did the SGR come to be? If it goes away, what will happen to the misplaced focus on physician payments?Squamoid Eccrine Ductal Carcinoma: A Diagnostic Challenge
https://practicaldermatology.com/youngmd-connect/resident-resource-center/squamoid-eccrine-ductal-carcinoma-a-diagnostic-challenge/23970/Squamoid eccrine ductal carcinoma is often initially misdiagnosed as squamous cell carcinoma.